From blockbuster drugs to blockbuster customer experience

The life sciences industry's commercial model is still mostly centered around the concept of driving blockbuster-type drugs. This approach, however, increasingly fails to deliver commercial success as the industry’s portfolios are shifting toward specialized drugs, complex drugs, personalized medicine and owning entire disease categories with various products to drive better health outcomes.

The fundamentals of delivering blockbuster customer experience requires new approach towards customer experience transformation strategy, customer journey and engagement, capability reorganization, and data & analytics.

16 OCT 2019
Hilton Philadelphia at Penn's Landing
Download Brochure Download Summary

16 OCT 2019

Keynote 1 - Connected Health At The Speed Of Life | David Blair, Google

The velocity of technological innovation has made its way into every aspect of daily life. It has rapidly changed the way we consume health information, seek treatment and has had a major impact on the patient/doctor relationship. These unprecedented advances in technology combined with more informed and demanding patients continue to disrupt care delivery and create new risks and opportunities for pharma companies. This presentation will focus on the key technology trends shaping patient behaviour and the commercial landscape, the move from point of care to care everywhere, and focus on the need to love data, speed up, and provide assistance as fundamental tenets for business success in the 21st Century.

16 OCT 2019

Keynote 2 - Managing Digital Journeys ft. Neil Jordan, Microsoft

16 OCT 2019

Keynote 3 - Advancing Life Sciences With ML ft. Shez Partovi, AWS

16 OCT 2019

Evolving Role Of AI Technologies ft. Tarun Mathur, Indegene

16 OCT 2019

Indegene CEO's Closing Remarks ft. Manish Gupta, Indegene

16 OCT 2019

Fireside Chat with Pharma & Biotech

Blockbuster Customer Experience

Customers require a more meaningful and relevant dialogue as their need for quality information is increasing and therefore, commercial success depends on providing the right treatment to the right patient. As the lifetime value of these customers grows along with their expectations for more value and ease of engagement, it has become a matter of survival for pharmas to accelerate their digital evolution and deliver a blockbuster customer experience.

3 Key Highlights

Customer Experience
Let Customer Experience Obsession drive business outcomes

Cross Industry Learning
Explore the best practices from other industries contextualised for pharma

Interact, Inspire, Engage
Network with senor thought leaders and meet CX-driven talent

300+
Attendees
30+
Speakers & Panelists
9
Sessions & Keynotes
Wednesday, October 16, 2019

Customer Experience Transformation - Organization mindset shift

  • Changing Customer Expectations - Challenges and Opportunities for Pharma
  • Customer Experience Focus Across the Organization
Wednesday, October 16, 2019

Customer Journey And Engagement - Content Strategy

  • Evolution of Content Strategy and Its Impact on Content Supply Chain
  • Is Next-Gen Modular Content the Future of Digital Supply Chain?
Wednesday, October 16, 2019

Capability Reorganization - Next-gen marketer

  • Is the Traditional Marketer Role Now Obsolete?
  • Reimagining Commercial Operations for Global, Local, and Regional Markets
Wednesday, October 16, 2019

Data And Analytics - Actionable Insights

  • Your CX Program Is Only as Good as What You Measure
  • Bringing Analytics to the Point of Decision-making for Patients and Physicians

Keynote Speakers

David Blair
David Blair
Head of Industry, Healthcare
Neil Jordan
Neil Jordan
Worldwide General Manager, Retail Health Innovation
Shez Partovi
Shez Partovi
Worldwide Lead - Healthcare, Life Sciences, Genomics

Speakers

Jeff S. French
Jeff S. French
Vice President and Chief Digital Officer, ViiV Healthcare
John McCarthy
John McCarthy
Principal Consultant, DT Consulting
Marc Schwartz
Marc Schwartz
Global Multi-Channel Marketing Lead, SANOFI
Mark Simon
Mark Simon
Partner and Co-Founder, Torreya Investment Bank
Michele Holcomb
Michele Holcomb
Cardinal Health
EVP, Strategy and Corporate Development
Nancy Phelan
Nancy Phelan
CEO
Adhera Therapeutics
Nathan Bowmaker
Nathan Bowmaker
Head of Global Commercial Operations, AstraZeneca
Nina (Christiane) Belly
Nina (Christiane) Belly
Global Medical Affairs Information Transformation and Capability Realization Lead
MSD
Raakhi K. Sippy
Raakhi K. Sippy
Global Head of Marketing Operations & 3rd Party Partnerships, GSK
Sanjeev Agarwal
Sanjeev Agarwal
Chairman
Althera Pharma
Anil Namboodiripad
Anil Namboodiripad
SVP, Proprietary Products, & President - Promius Pharma
Shane J. Schaffer
Shane J. Schaffer
Chairman & CEO, Cingulate Therapeutics
Ashish Sharma
Ashish Sharma
Executive Director, Data and Platform: Commercial Effectiveness, US Pharma
Novartis
Shawn Ferry
Shawn Ferry
Vice President, Marketing & Integrated Multichannel Strategies, Teva
Barbara Salami
Barbara Salami
Head, Customer Experience Optimization, US Pharma, GSK
Tara Stewart
Tara Stewart
Worldwide Head, Multi-Channel Hub, Bristol-Myers Squibb
Craig Mcgettigan
Craig Mcgettigan
Head, Multichannel Engagement, US Business Operations and Support
Sanofi
Tim Van Tongeren
Tim Van Tongeren
Managing Partner
DT Consulting
Dave Lenon
Dave Lenon
President
AveXis, Inc.
Tina Goyal
Tina Goyal
Global Head Marketing Innovation & Execution, Novartis
Dave Tang
Dave Tang
VP, Global Medical Office
Allergan
Venu Gopalakrishnan
Venu Gopalakrishnan
Sr Director, Decision Support and Market Analytics
Amicus Therapeutics
David Kreutter
David Kreutter
Sr Lecturer, Columbia University and Former VP, Global Business Analytics and Insights
Pfizer